Reckitt sales marginally beat full-year estimates

Britain's Reckitt Benckiser , maker of Dettol and Lysol cleaning products, on Wednesday marginally beat full-year like-for-like net revenue expectations, helped by its nutrition and health businesses.

The company said it would target like-for-like net revenue growth of mid-single digits for 2023, excluding the lapping of about a 2.5% impact related to the United States' supply disruption in infant formula. Reckitt, which also makes Nurofen tablets, cold remedy Lemsip and Durex condoms, said full-year like-for-like net revenue increased by 7.6% to $13.66 billion pounds ($16.47 billion), edging analysts' expectations of a 7.5% rise, according to a company-provided consensus.

Full-year adjusted earnings rose 16.8% to 3.44 billion pounds. ($1 = 0.8294 pounds)

(This story has not been edited by Devdiscourse staff and is auto-generated from a syndicated feed.)